BVS
Bioventus Inc
12.80$
-2.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 15 | Q1 16 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 31.5% | 29.4% | 28.1% | 28.1% | 26.4% | 24.7% | 27.2% | 30.5% | 27.3% | 25.5% | 27.2% | 30.5% | 27.4% | 32.7% | 35.5% | 31.1% | 34.3% | 41.0% | 37.9% | 35.0% | 34.7% | 36.3% | 31.7% | 31.5% | 32.7% | 33.2% | 34.2% | 31.8% | 33.0% | 31.9% | 32.1% | 31.0% | 32.0% | |
| 68.5% | 70.6% | 71.9% | 71.9% | 73.6% | 75.3% | 72.8% | 69.5% | 72.7% | 74.5% | 72.8% | 69.5% | 72.6% | 67.3% | 64.5% | 68.9% | 65.7% | 59.0% | 62.1% | 65.0% | 65.3% | 63.7% | 68.3% | 68.5% | 67.3% | 66.8% | 65.8% | 68.2% | 67.0% | 68.1% | 67.9% | 69.0% | 68.0% | |
| 5.6% | 5.7% | 3.2% | 3.2% | 3.5% | 3.2% | 2.7% | 4.5% | 4.2% | 2.9% | 1.2% | 4.4% | 5.7% | 5.4% | 5.9% | 4.5% | 3.6% | 5.4% | 3.2% | 2.5% | 2.5% | 2.4% | 2.0% | 2.8% | 2.7% | 2.1% | 2.4% | 2.1% | 2.1% | 1.9% | 1.9% | 2.1% | 2.0% | |
| – | – | – | – | – | 55.8% | 51.2% | 69.9% | 58.5% | 60.1% | 236.1% | 62.9% | 64.5% | 59.0% | 73.7% | 64.1% | 65.5% | 57.4% | 68.2% | 54.8% | 57.8% | 55.0% | 60.6% | 62.7% | 58.4% | 56.4% | 59.3% | 53.6% | 56.7% | 52.4% | 59.3% | 54.0% | 55.4% | |
| 99.4% | 73.7% | 67.6% | 67.6% | 60.8% | 61.2% | 56.3% | 77.5% | 64.6% | 68.5% | 45.9% | 74.7% | 73.6% | 69.7% | 82.8% | 71.2% | 164.3% | 79.2% | 139.4% | 60.1% | 63.3% | 62.9% | 64.5% | 89.3% | 64.4% | 61.6% | 61.7% | 55.6% | 58.2% | 54.3% | 61.2% | 56.5% | 57.4% | |
| -30.5% | -3.1% | 4.3% | 4.3% | 12.9% | 14.0% | 16.5% | -7.9% | 8.1% | 6.0% | 26.9% | -5.2% | -1.0% | -2.4% | -18.3% | -2.4% | -98.6% | -20.2% | -77.3% | 4.9% | 2.0% | 0.9% | 3.8% | -20.8% | 2.9% | 5.2% | 4.0% | 12.6% | 8.7% | 13.8% | 6.7% | 12.5% | 10.6% | |
| 7.2% | 5.4% | – | – | – | 7.8% | 3.0% | 4.9% | 2.2% | 2.7% | 3.5% | 1.5% | 1.2% | 0.7% | 0.6% | 1.8% | 2.8% | 11.8% | 8.1% | 7.7% | 8.4% | 7.6% | 8.0% | 6.6% | 6.9% | 5.9% | 6.1% | 5.1% | 4.5% | 3.4% | 3.3% | 2.7% | 3.4% | |
| -38.7% | -8.3% | -1.6% | -1.6% | 7.3% | 6.4% | 13.4% | -10.5% | 9.7% | 3.2% | 29.9% | -8.3% | -2.9% | -3.5% | -16.7% | -4.6% | -101.5% | -39.5% | -84.1% | -3.2% | -6.8% | -6.2% | -4.2% | -27.5% | -3.5% | 0.2% | -2.8% | 7.0% | 3.4% | 9.0% | 3.4% | 10.0% | 6.6% | |
| 0.7% | 0.9% | 0.2% | 0.2% | 0.4% | 0.9% | 0.0% | -0.2% | 0.4% | 0.9% | -0.1% | 1.6% | -0.8% | -2.1% | -4.4% | 0.9% | -22.9% | -3.8% | -0.1% | 0.3% | 0.5% | -0.6% | 0.7% | -4.9% | 0.4% | 0.4% | -0.1% | 0.7% | 0.5% | -2.0% | 0.4% | -13.6% | -3.9% | |
| -39.4% | -9.2% | -2.8% | -3.6% | 5.1% | 5.8% | 13.9% | -9.9% | 9.8% | 2.8% | 30.5% | -3.8% | -1.0% | -0.3% | -9.6% | -5.2% | -84.1% | -25.4% | -116.9% | -2.7% | -6.0% | -4.5% | -3.8% | -17.0% | -3.5% | -0.1% | -2.1% | 5.1% | 2.3% | 9.3% | 2.4% | 21.8% | 9.4% | |
| 4.0% | 13.1% | 10.3% | 10.3% | 21.8% | 21.7% | 25.8% | 4.6% | 20.4% | 12.8% | 35.7% | 7.3% | 6.2% | 6.2% | -6.9% | 6.0% | -88.1% | -9.3% | -62.2% | 15.2% | 13.0% | 10.6% | 12.9% | -12.3% | 12.2% | 14.1% | 12.9% | 20.2% | 16.0% | 19.7% | 15.2% | 12.6% | 16.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.